This topic contains a solution. Click here to go to the answer

Author Question: When asked to identify the most negative aspects of their husband's retirement, most wives point ... (Read 79 times)

HudsonKB16

  • Hero Member
  • *****
  • Posts: 535
When asked to identify the most negative aspects of their husband's retirement, most wives point to:
 
  a. his loss of status.
  b. financial problems.
  c. the lack of privacy.
  d. his declining interest in sex.

Question 2

According to Sternberg, intimacy without passion or commitment is called:
 
  a. liking.
  b. companionate love.
  c. nonlove.
  d. empty love.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

sarah_brady415

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

B

Answer to Question 2

A




HudsonKB16

  • Member
  • Posts: 535
Reply 2 on: Jun 18, 2018
:D TYSM


emsimon14

  • Member
  • Posts: 344
Reply 3 on: Yesterday
Excellent

 

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

ACTH levels are normally highest in the early morning (between 6 and 8 A.M.) and lowest in the evening (between 6 and 11 P.M.). Therefore, a doctor who suspects abnormal levels looks for low ACTH in the morning and high ACTH in the evening.

Did you know?

Prostaglandins were first isolated from human semen in Sweden in the 1930s. They were so named because the researcher thought that they came from the prostate gland. In fact, prostaglandins exist and are synthesized in almost every cell of the body.

Did you know?

Ether was used widely for surgeries but became less popular because of its flammability and its tendency to cause vomiting. In England, it was quickly replaced by chloroform, but this agent caused many deaths and lost popularity.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library